| | Abbott Laboratories Inc. Illinois | USA | | Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and |
|
| | InterMune , Inc. California | USA | | InterMune, Inc., is a biopharmaceutical company focused on developing and commercializing innovative therapies in hepatology and pulmonology |
|
| Genzyme Corporation Massachusetts | USA | | One of the world's leading biotechnology companies, Genzyme is dedicated to making a major positive impact on the lives of people with serio |
| | Gilead Sciences , Inc. California | USA | | Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical |
|
| Cephalon , Inc. Pennsylvania | USA | | Founded in 1987, Cephalon, Inc. is an international biopharmaceutical company dedicated to the discovery, development and marketing of innov |
| | ZymoGenetics , Inc. Washington | USA | | ZymoGenetics creates novel protein drugs with the potential to significantly help patients fight their diseases. The Company is developing a |
|
| Tranzyme , Inc. Quebec | Canada | | Tranzyme Pharma is developing proprietary therapeutic candidates from its own medicinal chemistry platform to treat underserved diseases of |
| | Celera Genomics Group | USA | | Celera Diagnostics compares genotype and/or gene expression profiles in samples from healthy and affected individuals to associate genetic a |
|
| |
| Curis , Inc. Massachusetts | USA | | Curis will be positioned to identify and successfully commercialize therapeutic opportunities derived from the human genome program , said D |
| | Serono , Inc. Massachusetts | USA | | Serono is a global biotechnology leader. The Company has eight biotechnology products, Rebif®, Gonal-f®, Luveris®, Ovidrel®/Ovitrelle®, |
|
| Sanofi Pasteur Inc. Pennsylvania | USA | | Sanofi pasteur, the vaccines business of sanofi-aventis Group, is the largest company in the world devoted entirely to human vaccines. In 20 |
| |
| |
|
